| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
7e-06 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
1e-05 |
| mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
1e-05 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
6e-05 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
7e-05 |
| mRNA |
AZD8055 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
9e-05 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0002 |